|
More info...
Vancouver, BC, July 2, 2009--(T-Net)--Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP. ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for patients with elevated low-density lipoprotein (LDL) cholesterol, or "bad" cholesterol, who are not well served by current ...
Cholesterol OK? Statins Still Help Heart (WebMD)
Millions of people without established heart disease could benefit from cholesterol-lowering statin therapy even if they don't have high cholesterol, a new analysis suggests.
Protein-rich diet linked to liver cancer (The Times of India)
Diets high in protein and cholesterol are linked with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk, according to the latest research.
Red yeast rice demonstrates cholesterol-lowering potential (Nutraingredients.com)
The herbal supplement was found to be effective in reducing the low-density lipoprotein (LDL) cholesterol level among 62 patients with hyperlipidemia and a history of discontinuation of statin therapy due to myalgias.
Newly discovered gene regulates balance of 'bad' cholesterol (PhysOrg)
In an article in Science, Noam Zelcer from the LACDR (The Netherlands) describes a previously unknown mechanism for regulating the amount of LDL cholesterol. This offers opportunities for supplementing and improving the effect of so-called statins: medicines that remove 'bad' cholesterol from the bloodstream.
|
